Vertex Pharmaceuticals (VRTX) Construction in Progress (2011 - 2012)
Vertex Pharmaceuticals' quarterly Construction in Progress came in at $223.1 million in Q3 2012, up 305.12% quarter-over-quarter from $55.1 million in Q4 2011.
Vertex Pharmaceuticals has reported Construction in Progress for 2 years, with the latest figure at $223.1 million in Q3 2012.
- For the quarter ending Q3 2012, Construction in Progress changed N/A year-over-year to $223.1 million; the trailing twelve-month figure through Sep 2012 stood at $223.1 million (changed N/A YoY), and the FY2011 full-year result was $55.1 million, changed N/A from the prior year.
- Construction in Progress for Q3 2012 stood at $223.1 million, up from $55.1 million in the prior quarter.
- The five-year high for Construction in Progress was $223.1 million in Q3 2012, with the low at $55.1 million in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 223.10 Mn |
| Dec 31, 2011 | 55.07 Mn |